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hyperﬁltration will in the long term be detrimental. Indeed,
Bankir and colleagues showed in an animal model that long-
term administration of a vasopressin V2 receptor agonist
caused an increase in proteinuria and a more rapid decline in
renal function.4 In analogy, we described recently that higher
baseline endogenous vasopressin levels were associated with a
more rapid decline in renal function during follow-up in a
cohort of renal transplant recipients.5 In our opinion, our
data and those of Bankir and colleagues are therefore not
contradictory, but in line.
Second, Dr Cirillo raises the suspicion that the association
between vasopressin and albuminuria might not be due to the
effects of vasopressin per se, but may be the result of another
variable that determines vasopressin release, such as salt
intake. He argues that a high salt intake could induce a higher
plasma osmolarity and thus vasopressin release, and that a
high sodium intake is also associated with albuminuria, but
through another mechanism. Of note, we previously indeed
described an association between sodium intake and albumi-
nuria in the Prevention of Renal and Vascular Endstage
Disease (study) cohort.6 In response to this question, we
added sodium intake (assessed as 24-h urinary sodium
excretion) to our multivariate model. The addition of sodium
intake did not change the beta value in males (0.09
(P¼ 0.001) vs 0.09 (P¼ 0.001), respectively), and only
marginally changed the value in females (from 0.17
(Po0.001) to 0.15 (Po0.001)). This observation makes it
less likely that high salt intake is the common factor that
induces an increase in albuminuria as well as in vasopressin,
and pleads for the option that vasopressin per se is
detrimental.
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Psychological risk factors of
kidney transplant patients
To the Editor: The quality of life of patients suffering from
end-stage renal disease remarkably improves after kidney
transplantation,1,2 but up to 71% of the patients suffer from
psychiatric disorders such as depression or anxiety in the long
run. Moreover, patients run the risk of low medication
adherence or even early loss of graft.3,4
In a prospective study, we examined 91 patients (51 male,
40 female) immediately after transplantation, and at 3 and
6 months later. Psychometric tests assessed the quality of life,
coping activities, psychological status, and personal resources/
social support.
We found signiﬁcant differences between self-assessment and
testing results. Patients had improved quality of life and felt
somatically healthy. Nevertheless, depression and anxiety
increased in a signiﬁcant manner (72.5% increased scores of
anxiety, 47.3% increased scores of depression). Risk factors were
gender, age, and family status. Men recovered signiﬁcantly better
than women (P¼ 0.011). Older patients suffered signiﬁcantly
more from anxiety (P¼ 0.005) and depression (P¼ 0.015).
Solitary persons had signiﬁcantly lower scores in all examined
ﬁelds. There was a high incidence of ineffective coping strategies.
Ineffective coping was correlated with gender (P¼ 0.013),
employment (P¼ 0.020), and coherence (P¼ 0.028).
Despite the good somatic results of kidney transplantation
there were serious deﬁcits in coping strategies. More than one
third suffered from anxiety and depression. Unexpectedly,
there were considerable discrepancies between self-assessment
and testing results. Therefore, constant psychological after-care
is urgently necessary. Further studies are necessary to improve
psychotherapeutic after-care and knowledge about the relation-
ship between psychological status and somatic outcome.
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